The American Law Institute's Restatement of the Law of Medical Malpractice, approved at the 2024 Annual Meeting and circulating in successive drafts and now Official Text since, has begun appearing in trial-court orders on motions in limine over expert qualification. The shift from a customary-practice standard to a reasonable-care standard, expressly informed by evidence-based guidelines, is incremental in case law but is significant enough that plaintiff firms with active medical malpractice dockets should be tracking adoption patterns by jurisdiction.
The Doctrinal Shift
The traditional black-letter rule in most jurisdictions held a physician to the standard of care customarily practiced by physicians of similar training and experience under similar circumstances. The customary-practice formulation gave deference to professional consensus as evidenced by expert testimony, with the implicit assumption that the prevailing professional norm represented the relevant duty.
The Restatement reframes the standard around reasonable care. Reasonable care is defined as the skill and knowledge regarded as competent among similar medical clinicians under comparable circumstances, with the explicit acknowledgement that juries may override customary practice where the practice falls short of contemporary standards. Evidence-based guidelines published by recognized specialty societies are admissible and, in some formulations, presumptively sufficient to establish the standard of care. Adherence to such guidelines is sufficient but non-adherence alone is not negligent.
The framing is not a wholesale rejection of expert testimony. Expert witnesses remain central to translating clinical evidence into a duty narrative. But the Restatement opens the door to admissibility of guideline-based evidence on its own terms and reduces the deference courts have historically given to the "what most doctors do" argument.
What This Changes for Plaintiff Case-Building
Plaintiff firms should expect three principal practical shifts as state courts adopt or cite the Restatement.
First, source selection for expert opinions will require more attention to which guidelines and which specialty-society publications carry weight in the jurisdiction. Expert reports that anchor opinions to specific guideline citations are now more defensible against Daubert and Frye challenges than reports that rest on the expert's clinical experience alone. The corollary is that opposing experts will more aggressively attack guideline selection, citing competing publications or older versions of the same guideline.
Second, document-discovery requests should target the defendant institution's adopted guidelines, internal protocols, and clinical pathways. Where a hospital or practice has formally adopted a specific guideline, deviation from that guideline is direct evidence of departure from the standard of care under the Restatement framework. Production requests should include guideline-adoption committee minutes, protocol revision history, and education materials distributed to staff.
Third, expert-witness preparation must account for cross-examination on guideline selection and revision. Defense counsel will press experts on why one guideline was selected over another, whether the guideline was current at the time of the alleged malpractice, and whether the guideline applies to the specific clinical scenario at issue. Plaintiff experts who cannot defend their guideline choice with reference to issue date, sponsoring society credibility, and evidentiary basis will lose ground that the Restatement is otherwise inviting them to take.
Procedural Touchpoints
Certificate-of-merit and affidavit-of-merit requirements vary by state, but the Restatement creates pressure on the threshold filings to identify guideline-based grounds for the negligence claim. Plaintiff firms in states with strict pre-suit requirements should consider adding a guideline-citation paragraph to standard affidavit templates, both to satisfy threshold requirements and to lock in the case theory before discovery.
Daubert and Frye admissibility motions are the most immediate battleground. Defense motions will argue that guideline-based opinions are insufficiently tied to the individual clinical facts. Plaintiff responses should establish the connection between guideline recommendation and the specific clinical decision at issue, which often requires the expert to lay out the differential the treating clinician should have considered and how guideline recommendations applied to each.
Jury instructions will require revision in adopting jurisdictions. The Restatement's framing supports instructions that allow juries to weigh customary practice against evidence-based guidelines and to find negligence where customary practice falls below the standard. Plaintiff firms should track instruction-revision activity at the state Pattern Jury Instruction level and submit comments where appropriate.
Interaction with Statutory Caps
Adoption of the Restatement framework does not affect statutory damages caps, which remain a separate doctrinal layer. Virginia's medical malpractice cap, for example, steps up to $2.75 million on July 1, 2026 under Virginia Code section 8.01-581.15, and continues to step up annually through 2031. The relevant date for cap application is the date of the alleged malpractice, not the date of filing, which matters for case-selection on stale matters.
Plaintiff firms in capped jurisdictions should not over-invest in the doctrinal shift where the cap is the binding constraint on case value. Where caps are high or where the underlying damages are non-economic-heavy, the Restatement framing remains relevant. Where the cap is low, the doctrinal change is significant only at the threshold of liability, not at the damages valuation. Coverage of state-by-state cap movement appears in our industry news reporting this week.
Adoption Patterns to Watch
Restatements influence state law through citation in appellate opinions. Practitioners should expect the Restatement to be cited first in jurisdictions with appellate courts that have historically been receptive to ALI work product, including New York, California, and the Third Circuit jurisdictions. States with stronger customary-practice traditions or active tort-reform legislatures may resist citation for several terms before lower courts pick it up.
Pattern Jury Instruction committees are likely to take longer than appellate courts because of the broader stakeholder consultation built into PJI revision. Plaintiff firms should track both layers because trial-court instructions and appellate opinions move on different timetables. Additional discussion of expert sourcing and discovery tactics under the new framework appears in our ongoing medical malpractice coverage.
Practical Bottom Line
The Restatement is not a sudden legal sea change. It is a slow doctrinal shift that will accumulate citations across the next several years. Plaintiff firms should add guideline citations to standard expert-report templates, refresh document-discovery requests with guideline-adoption targets, and prepare witnesses to defend guideline selection on cross-examination. Firms that adapt early will have stronger expert reports and cleaner motion records than firms that wait for jurisdiction-specific adoption to compel the change.